PHIO
HEALTHCAREPhio Pharmaceuticals Corp
$1.15+0.02 (+1.77%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PHIO Today?
No stock-specific AI insight has been generated for PHIO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.81$3.48
$1.15
Fundamentals
Market Cap$13M
P/E Ratio—
EPS$-1.45
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume147K
Avg Volume (10D)—
Shares Outstanding11.6M
PHIO News
20 articles- Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business UpdateYahoo Finance·May 7, 2026
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow SeriesYahoo Finance·Apr 23, 2026
- Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026Yahoo Finance·Apr 13, 2026
- Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026Yahoo Finance·Apr 9, 2026
- Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762Yahoo Finance·Mar 30, 2026
- Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline AdvancementYahoo Finance·Mar 23, 2026
- Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family OfficeYahoo Finance·Mar 16, 2026
- Life Sciences Virtual Investor Forum Presentations Now Available for Online ViewingYahoo Finance·Mar 13, 2026
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12thYahoo Finance·Mar 10, 2026
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDTYahoo Finance·Mar 10, 2026
- Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business UpdateYahoo Finance·Mar 5, 2026
- Phio Pharmaceuticals Corp. Selected as B2i Digital Featured CompanyYahoo Finance·Feb 23, 2026
- Phio Pharmaceuticals Aligns Leadership Team to Support Next Stage Development of PH-762 and Advancement of PH-894Yahoo Finance·Feb 19, 2026
- BC-Most Active StocksYahoo Finance·Feb 10, 2026
- Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer TrialYahoo Finance·Feb 10, 2026
- Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery ConferenceYahoo Finance·Jan 26, 2026
- Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma TrialYahoo Finance·Jan 20, 2026
- Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026Yahoo Finance·Jan 15, 2026
- Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762Yahoo Finance·Dec 23, 2025
- Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday TradingYahoo Finance·Dec 18, 2025
All 20 articles loaded
Price Data
Open$1.18
Previous Close$1.13
Day High$1.19
Day Low$1.13
52 Week High$3.48
52 Week Low$0.81
52-Week Range
$0.81$3.48
$1.15
Fundamentals
Market Cap$13M
P/E Ratio—
EPS$-1.45
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin—
Debt / Equity—
Trading
Volume147K
Avg Volume (10D)—
Shares Outstanding11.6M
About Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—